PTC Therapeutics (PTCT) PT Raised to $85 at RBC Capital
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $65.37 -3.87%
Rating Summary:
18 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
18 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $85.00 (from $82.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- JPMorgan Downgrades Mapletree Logistics Trust (MLT:SP) (MAPGF) to Neutral
- Dowa Holdings Co Ltd (5714:JP) PT Raised to JPY9,800 at Nomura/Instinet
- HubSpot Inc (HUBS) PT Raised to $290 at UBS, Stock Expected to Be Execution-Driven Near-Term
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
